PT Tifico Fiber Indonesia Tbk (IDX:TFCO)

Marinus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	3.11	2.94	3.3	3.42	13.56	-0.86
Depreciation & Amortization	2.08	4.13	4.62	5.92	9.51	13.15
Other Amortization	0.04	0.07	0.07	0.07	0.07	0.07
Other Operating Activities	15.76	5.15	6.56	-8.18	-5.26	8.75
Operating Cash Flow	20.99	12.3	14.55	1.22	17.89	21.11
Operating Cash Flow Growth	64.36%	-15.49%	1091.14%	-93.17%	-15.29%	-12.52%
Capital Expenditures	-1.44	-1.48	-3.55	-1.37	-0.42	-0.95
Sale of Property, Plant & Equipment	0.03	0.06	-	-	0.03	-
Investment in Securities	-	-6	7.95	-36.27	-2.82	-
Other Investing Activities	-	-	-	0	0	0.01
Investing Cash Flow	-1.41	-7.42	4.4	-37.63	-3.21	-0.94
Short-Term Debt Repaid	-	-1.67	-2.06	-2.7	-6.31	-1.18
Long-Term Debt Repaid	-	-	-	-0.14	-0.06	-
Total Debt Repaid	-2.14	-1.67	-2.06	-2.84	-6.37	-1.18
Net Debt Issued (Repaid)	-2.14	-1.67	-2.06	-2.84	-6.37	-1.18
Financing Cash Flow	-2.14	-1.67	-2.06	-2.84	-6.37	-1.18
Net Cash Flow	17.43	3.2	16.89	-39.25	8.3	18.99
Free Cash Flow	19.54	10.82	11	-0.14	17.47	20.17
Free Cash Flow Growth	104.21%	-1.67%	-	-	-13.37%	3.27%
Free Cash Flow Margin	10.26%	5.77%	5.61%	-0.06%	8.15%	13.56%
Free Cash Flow Per Share	0.00	0.00	0.00	-	0.00	0.00
Cash Interest Paid	0.03	0.03	0.05	0.04	0.04	0.05
Cash Income Tax Paid	-	-0.87	0.88	2.39	3.21	0.26
Levered Free Cash Flow	10.71	6.25	5.96	-0.11	10.59	13.37
Unlevered Free Cash Flow	10.74	6.27	5.99	-0.07	10.62	13.4
Change in Net Working Capital	-7.53	-3.22	-4.66	7.62	9.03	-1.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.